Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LPAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PIH1D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MMP28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00311 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPGS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHANK2-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AAGAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MNT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506609 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on